OUR PRODUCTS
Credo Diagnostics Biomedical develops point-of-care (POC) diagnostic technology.
Our nucleic acid diagnostic platform is designed to be used by any personnel with minimal training. Our solution covers sample preparation, amplification and detection through simple operating procedures with short turnaround time with no compromise on accuracy and sensitivity.
OUR VISION
We at Credo Diagnostics, the pioneers of accessible diagnostic platforms, want to improve the lives of those we love.
We believe providing the right information to the right people at the right time leads to better outcomes.
NEWS
-
2021-12-01The Change of Address
Credo Diagnostics develops and manufactures innovative, easy-to-use and rapid molecular diagnostic solutions for Point-of-Care (POC) applications at affordable costs without compromising accuracy and speed in the areas Human Health. Leveraging solid and established science, combined with efficient integration and strategic innovation, Credo Diagnostics Biomedical provides advanced medical technologies for all.
view more -
2021-11-29Analysis Shows Credo’s VitaPCR™ SARS-CoV-2 Related Assays are capable of detecting the new variant strain Omicron Variant correctly
Analysis Shows Credo’s VitaPCR™ SARS-CoV-2 Related Assays are capable of detecting the new variant strain Omicron Variant correctly.
view more -
2021-01-01Analysis Shows Credo’s VitaPCR™ SARS-CoV-2 Related Assays Covers New Virus Strainview more
VitaPCR™ SARS-CoV-2 Related Assays Covers New Virus Strain
CONTACT
We at Credo Diagnostics pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.
SUBSCRIBE TO NEWSLETTER
Subscribe to our newsletter to receive latest news on our products and services.